Interpreting the value proposition of RWD/RWE data

Real-World Data (RWD) and Real-World Evidence (RWE) are revolutionizing healthcare by providing evidence and insights from real-life experiences. This helps healthcare stakeholders make informed decisions and result in improved patient outcomes. As per Jasper Colin’s recently conducted study, the global RWE market is expected to reach $5.2 billion by 2030, with a growth rate of 13.9%. This growth is driven by the growing availability of RWD and its adoption by pharmaceutical companies and healthcare providers for a deeper understanding of patient data.